Clinical trial begins in Bunia for Bundibugyo Ebola virus vaccines
A first participant has received a vaccine in Bunia as part of the "Tumaini" clinical trial in the Democratic Republic of the Congo. The trial is evaluating candidate vaccines targeting the Bundibugyo strain of the Ebola virus. Further details regarding the scale and duration of the trial have not yet been specified.
- actualite-cdRDC
- radiookapiBunia
Corrections and updates
No published correction or update is recorded. This does not reconstruct changes made before correction records were kept.
Cite this record
Global Event Monitor. Clinical trial begins in Bunia for Bundibugyo Ebola virus vaccines. 2026-10-24T08:09:17.153Z. Status: published. urn:global-events-monitor:event:7326. https://global.eventmonitor.net/event/2026-10-24/ebola-en-rdc-le-premier-participant-a-l-essai-clinique-10228f81
BibTeX · RIS · CSV · JSON · Corrections and updates · Captured versions